Myocardial reperfusion is a critical aspect of cardiovascular health, representing the restoration of blood flow to the heart muscle after a period of ischemia. Ischemia occurs when blood supply to the heart is temporarily reduced or blocked, often during a heart attack. Reperfusion aims to alleviate this condition and minimize damage to the heart tissue. However, the process itself can induce injury due to the sudden reintroduction of oxygen, leading to oxidative stress and inflammation. Researchers and healthcare professionals are continually exploring innovative strategies to optimize myocardial reperfusion, with a focus on minimizing adverse effects and enhancing overall cardiac recovery. Understanding the intricacies of myocardial reperfusion is crucial in advancing therapeutic approaches for cardiovascular diseases and improving patient outcomes.
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation